It recognizes it as a protein and processes it exactly the way it would process any dietary protein
The most common dose-related adverse effect is severe nausea and vomiting, which can escalate to dehydration and electrolyte imbalances
Incidence and risk of gastric neuroendocrine tumors and adenocarcinoma in patients with atrophic gastritis/pernicious anemia
Local reaction characteristics: Confined to the injection site and immediately surrounding area Symptoms include redness, swelling, itching, pain, and warmth at the injection site only No systemic symptoms (no fever, no hives elsewhere, no breathing difficulty) Resolves within 3 to 7 days Does not typically worsen after the first 24 to 48 hours Systemic allergic reaction characteristics: Symptoms extend beyond the injection site Hives, rash, or flushing on areas distant from the injection site Respiratory symptoms (coughing, wheezing, throat tightness) Cardiovascular symptoms (rapid pulse, low blood pressure, dizziness) Gastrointestinal symptoms (nausea, vomiting, cramping) beyond typical GI side effects Local reactions almost never require discontinuation of tirzepatide
Spacing meals evenly, choosing smaller portions, and avoiding very high-fat meals can help reduce post-meal symptoms
FAQ What makes IGF-1 DES special